Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr659 Inhibitors

Olr659 inhibitors represent a specialized class of chemical compounds designed to interact specifically with the olfactory receptor 659 (Olr659), a protein encoded by the Olr659 gene. These inhibitors are often characterized by their high affinity and selectivity for the receptor, making them valuable tools for probing the functional roles and mechanisms associated with Olr659. Structurally, Olr659 inhibitors can vary widely, encompassing small organic molecules, peptides, and other chemically synthesized entities. The specificity of these inhibitors towards Olr659 allows for the precise modulation of the receptor's activity, providing insights into its physiological functions. Researchers synthesize these inhibitors through various chemical processes, including traditional organic synthesis and combinatorial chemistry techniques, often followed by rigorous screening methods to ensure their efficacy and specificity.

The interaction between Olr659 inhibitors and their target receptor is typically studied using a combination of biochemical assays, molecular modeling, and spectroscopic techniques. These studies aim to elucidate the binding kinetics, conformational changes, and downstream signaling pathways initiated by the receptor upon inhibitor binding. Additionally, advanced techniques such as X-ray crystallography and cryo-electron microscopy are employed to visualize the inhibitor-receptor complexes at atomic resolution, offering a detailed view of the molecular interactions involved. Understanding the exact binding sites and the nature of the interactions can help in the rational design of more potent and selective inhibitors. Such comprehensive studies contribute significantly to the broader understanding of olfactory receptors and their role in various biological processes, further advancing the field of chemical biology and molecular pharmacology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

KPT 330

1393477-72-9sc-489062
5 mg
$170.00
(0)

Inhibits nuclear export protein XPO1, potentially affecting protein localization and function.

MEK 162

606143-89-9sc-488879
10 mg
$306.00
(0)

MEK inhibitor, potentially disrupting proteins in the MAPK/ERK pathway.

Talazoparib

1207456-01-6sc-507440
10 mg
$795.00
(0)

PARP inhibitor, potentially affecting proteins involved in DNA repair pathways.

Lapatinib

231277-92-2sc-353658
100 mg
$412.00
32
(1)

Dual inhibitor of EGFR and HER2, potentially disrupting proteins in associated signaling pathways.

Rucaparib

283173-50-2sc-507419
5 mg
$150.00
(0)

PARP inhibitor, potentially affecting proteins involved in DNA repair pathways.

BIBF1120

656247-17-5sc-364433
sc-364433A
5 mg
10 mg
$180.00
$315.00
2
(0)

Inhibits VEGF receptors, FGFR, and PDGFR, potentially affecting proteins involved in angiogenesis and tumor growth.

Acalabrutinib

1420477-60-6sc-507392
250 mg
$255.00
(0)

Bruton's tyrosine kinase inhibitor, potentially influencing proteins in B-cell receptor signaling pathways.